Eris Lifesciences launched its version under the brand SUNDAE at 220 per shot, with a pen device expected in April priced between 4,000 and 4,500 per month
For most people, missing one weekly injection is not dangerous
Disorders included in the literature review were depression and anxiety, addiction-related disorder (food addiction), eating disorders (bulimia nervosa and binge-eating disorder), ADHD and ASD
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Center for Complementary and Integrative Health (NCCIH) both acknowledge the evidence base for GLP-1 receptor agonists in obesity medicine as part of the broader federal research and clinical guidance infrastructure
Discontinuation and reinitiation patterns are not well understood
The targeted nature of this compound makes it a preferred option in Europe peptide therapies aimed at building lean muscle mass and enhancing physical performance